GRANT HENRY: Open Payments
NPI 1710935234 · VICTORIA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$662 in 34 payments from 12 companies in 2025. Trend: 2023 $583 · 2024 $684 · 2025 $662
Food & beverage: $662
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 9 | $184 |
| Amgen Inc. | 10 | $135 |
| PFIZER INC. | 4 | $74 |
| Novo Nordisk Inc | 2 | $69 |
| Boston Scientific Corporation | 1 | $57 |
| GlaxoSmithKline, LLC. | 2 | $42 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
| ABBVIE INC. | 1 | $19 |
| Dexcom, Inc. | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
Products named: MOUNJARO, OTEZLA, NURTEC ODT, WATCHMAN FLX, Ozempic, SHINGRIX, AREXVY, LEQVIO.
Industry payments across TX — which companies pay providers there.
